By Jim English

Vital Cell® is an advanced herbal formula designed to counter a host of common discomforts associated with human aging. By restoring microcirculation, Vital Cell has been shown to improve internal organ function and speed removal of toxic cellular metabolic waste products, such as lipofuscin, that are implicated in a wide range of age-related degenerative conditions. Vital Cell has also been shown to support the immune system by increasing resistance to illness and improving overall health.

Order Vital Cell now with code BLD9W for special price.

The following summary is condensed from a clinical trial involving 150 patients between the ages of 55 to 89 years. In this study the researchers set out to quantify changes in several biological markers that serve as important indicators of the human aging process. Researchers conducted detailed medical examinations of each patient prior to the start of the trial, and again at the end of the 30-day treatment phase. After evaluating their data, the researchers discovered significant improvements in a wide range of symptoms.
Angina, Chest Tightness, Palpitations

With advanced age, arteries tend to thicken as fatty deposits accumulate on the inner lining of arterial walls, especially in the coronary and cerebral arteries. These deposits reduce arterial circumference and impair blood vessel elasticity, resulting in a lack of blood flow to heart tissues. Common symptoms usually include chest distress, palpitations, insomnia, and pain due to insufficient blood supply to the coronary arteries.

Angina: Prior to treatment, 25 patients were diagnosed with angina pectoris. After one month of treatment, 23 of the 25 patients (92%) were completely free of symptoms, and the remaining two patients reported that their symptoms were significantly reduced.

Chest Tightness: Before taking Vital Cell , 106 patients reported experiencing chest pains. After receiving Vital Cell for one month, only two of the 106 patients (1.9%) continued to feel chest pains.

Palpitations: Of 86 patients experiencing unpleasant sensations, including irregular and/or forceful beating of the heart, 82 reported complete relief from symptoms one month after treatment, and only four patients reported continued symptoms.
Coughing, Shortness of Breath

Human aging is associated with the partial or complete wasting (atrophy) of the adrenal cortex and sex glands, resulting in the deterioration of the mononuclear phagocyte system (part of the immune system) and a decline in antibody production for protection from infection. Other factors, such as a narrowing or obstruction of the pulmonary arteries, contribute to inflammation of the bronchial walls, resulting in lung congestion, edema, fibroblastic proliferation and narrowing of the bronchial tubes. Symptoms include chronic coughing and shortness of breath.

Coughing: Before receiving Vital Cell, the patients were questioned about their coughing patterns. Coughing fits lasting five minutes or longer, and occurring in both the morning and evening, were considered diagnostically relevant. Thirty-six patients reported that they experienced bouts of coughing lasting longer than five minutes in both morning and evening. After taking Vital Cell for one month, 34 patients reported improvement (94%), and only two cases reported coughing fits still lasting for more than five minutes.

Shortness of Breath: To determine shortness of breath, all 150 patients were required to climb one flight of stairs, after which their breathing was monitored and recorded. These records were compared to records gathered at intake. At the start of the study, 42 patients experienced shortness of breath during the stair test. At the conclusion of the study only seven patients still experienced shortness of breath, while 35 patients (83%) were able to complete the stair test without difficulty. The difference was statistically significant (P

I believe depression needs to be tackled with a range of treatments, especially non-drug options such as meditation, talking therapies and exercise.

So I'm appalled that a meditation-based therapy which works - and was recommended by advisory body NICE five years ago - is still largely unavailable on the NHS.

A report released yesterday by the Mental Health Foundation reveals that only one in five GPs have access to the therapy, known as mindful meditation.

It combines meditation with yoga and cognitive behavioural therapy, an established technique that tackles negative thinking. Three-quarters of GPs say they still have to prescribe antidepressants due to lack of access to more effective alternatives.

It's a crying shame as mindful meditation is clinically proven to cut the risk of a relapse by half. This could make a huge difference as one in 10 people will be affected by clinical depression at some point.

What's more, the therapy itself is extremely cost-effective - an eight-week course, consisting of a weekly two-hour group session, costs £300 per patient on average.

So surely, in these cash-strapped times, we should encourage a low-cost alternative to the mounting bill of long-term medication. The number of prescriptions made for antidepressants each year in England alone has doubled to 36million in the past decade.

I'm not against antidepressants. They are lifesavers for some people with severe depression and can be used alongside other therapies if necessary.

But the reason I'm so keen on this mind-based therapy is that it provides you with lifelong tools to tackle problems such as depression, anxiety, stress and addiction.